Noritren (Nortriptyline Hydrochloride)

Nortriptyline is a tricyclic antidepressant that modulates neurotransmitter pathways involved in mood and pain perception.

• Major depressive disorder: alleviates depressive symptoms and improves mood.
• Depressive episodes associated with bipolar disorder: helps stabilize depressive phases.
• Chronic neuropathic pain: reduces pain intensity and improves functional ability.
• Migraine prophylaxis: decreases frequency and severity of migraine attacks.

• Nortriptyline inhibits the reuptake of norepinephrine and serotonin, increasing their synaptic concentrations. It also antagonizes muscarinic acetylcholine, histamine H1, and α1‑adrenergic receptors, contributing to its analgesic, sedative, and antihistaminic properties while influencing central pain pathways.

Nortriptyline may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Dry mouth: reduced salivary flow leading to discomfort.
• Constipation: slowed gastrointestinal motility.
• Drowsiness or sedation: increased sleepiness.
• Weight gain: increased appetite or metabolic changes.
• Blurred vision: temporary visual disturbances.
• Urinary retention: difficulty emptying the bladder.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm, especially in patients with pre‑existing heart disease.
• Seizures: heightened risk in susceptible individuals.
• Severe hypotension: sudden drop in blood pressure.
• Blood dyscrasias: abnormal blood cell counts.
• Suicidal thoughts: emergence or worsening of suicidal ideation.
• Severe allergic reactions: rash, swelling, or anaphylaxis.

Before initiating therapy with Nortriptyline, clinicians should evaluate several safety factors.

• Cardiac assessment: review history of heart disease and consider ECG monitoring.
• Blood pressure monitoring: watch for orthostatic hypotension.
• Liver function: assess hepatic impairment as dosage may need adjustment.
• Elderly patients: start with lower doses due to increased sensitivity.
• Discontinuation: avoid abrupt cessation to reduce withdrawal symptoms.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nortriptyline interacts with several drug classes; careful review is essential.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Selective serotonin reuptake inhibitors (SSRIs) or serotonin‑norepinephrine reuptake inhibitors (SNRIs): potential serotonin syndrome.
• Certain antiarrhythmic agents (e.g., quinidine): may exacerbate cardiac toxicity.

Moderate Interactions (Monitor Closely)

• Antihistamines and anticholinergics: additive anticholinergic effects.
• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increase nortriptyline plasma levels.
• Alcohol or CNS depressants: enhanced sedation and respiratory depression.